Ambien, made by Sanofi-Aventis (nyse: SNY - news - people ), lost patent protection on April 21. Dr. Reddy's and several other companies had previously ...
Last week, Mylan was approved on a generic version of Ambien, and Barr said earlier this month it has initiated a patent challenge to Ambien, as it prepares ...
Ambien's protection expired on April 20 and several generic manufacturers have already received regulatory authorisation to produce a version of Ambien. ...
More than a dozen prescription medications fall into the same class of sleep disorder drugs as Ambien, and together they account for some 44 million ...
The US Food and Drug Administration is allowing the manufacture and sale of generic versions of Ambien, a move that usually lowers costs for consumers. ...
Spek said Sanofi could lose $1 billion in revenue this year from the sleep aid Ambien MR to generic competition. Teva Pharmaceutical Industries launched ...